X’s case is only latest in shocking saga of children’s mental health care

X’s case is only latest in shocking saga of children’s mental health care

Judge’s candour over ‘disgraceful lack of provision’ for vulnerable 17-year-old again highlights CAMHS’ inadequacy – but nothing changes Sir James Munby’s 19-page judgment on X’s situation contains many views expressed with notably more candour than appeal court judges usually deploy. But one in particular will resonate with children with mental health problems and their families who have…

First hints Parkinson’s can be stopped

First hints Parkinson’s can be stopped

It may be possible to stop the progression of Parkinson’s disease with a drug normally used in type 2 diabetes, a clinical trial suggests. Current drugs help manage the symptoms, but do not prevent brain cells dying. The trial on 62 patients, published in the Lancet, hints the medicine halted the progression of the disease….

At least 60 UK drug deaths in past eight months linked to fentanyl

At least 60 UK drug deaths in past eight months linked to fentanyl

National Crime Agency repeats warning to be vigilant after synthetic opioid found in toxicology tests of 60 who died At least 60 drugs deaths in the UK in the past eight months have been linked to fentanyl, an opioid that is being mixed with street heroin to make it more potent. Releasing the figures, the…

More than 100,000 terminally ill patients denied hospice care

More than 100,000 terminally ill patients denied hospice care

One in four terminally ill people who need expert end-of-life care are not receiving it because of funding pressures, the hospice movement has told Sky News. Hospice UK said as many as 118,000 people in the UK with terminal or life-limiting conditions are not able to access palliative care from its members. Britain’s 200 hospices…

Nearly all men over 60 and women over 75 eligible for statins, analysis suggests

Nearly all men over 60 and women over 75 eligible for statins, analysis suggests

11.8 million adults in England are eligible to be offered cholesterol-lowering drugs, say researchers who examined 2014 guidance on statins set out by Nice Almost all men over 60 and women over 75 should be eligible for statins, according to a new analysis. After examining guidance on which patients should be offered statin therapy, researchers…